… Vaccine 2007; 25: 5399–5408. 12 Van de Velde N, Brisson M, Boily MC: Modeling human
papillomavirus vaccine … of a quadrivalent human papillomavirus vaccine in France. Int J …

… in this paper is how HPV vaccination ought to be handled in developed countries. Should
a market-oriented approach prevail or should general vaccination programs be introduced? If …

… had been conducted in other developed countries. More recently, a large number of new
evaluations for female HPV vaccination in developed countries throughout Europe and the Asia…

… had been introduced into national immunization programs in at least 40 countries. … countries
to introduce HPV vaccination. In Europe, the number of countries having introduced vaccine …

… low-income countries. By 2014, more than 57 countries had included the HPV vaccine in
their … Data from several countries have shown the effect of vaccination on HPV infection and …

… of human papillomavirus (HPV) vaccination programmes in developed and developing
countries. The review spans the period from establishment of long-term vaccine efficacy follow-…

… authorities, industry representatives, epidemiologists and government officials from both
developed and developing countries 1 to discuss appropriate endpoint measurements for HPV …

… For less developed countries, many women have been vaccinated through demonstration
projects, such as the Gardasil Access Program, which has shipped 1·3 million doses to 21 …

… Less-developed countries bear the greatest burden in terms of morbidity and mortality, … of
human papillomavirus (HPV). Two recently developed prophylactic cervical cancer vaccines, …

… Unfortunately, even in most highly developed countries, such a level of vaccination coverage
has not been consistently achieved. Critically, global estimates of HPV vaccination delivery …